2. Academic Validation
  3. Design and synthesis of Tetrahydroindeno[4,5-c]chromen-4(3H)-one derivatives as antiproliferative agents for prostate Cancer cells

Design and synthesis of Tetrahydroindeno[4,5-c]chromen-4(3H)-one derivatives as antiproliferative agents for prostate Cancer cells

  • Bioorg Med Chem Lett. 2026 Apr:133:130515. doi: 10.1016/j.bmcl.2025.130515.
Hui-Yu Chan 1,  Pin-Shuo Huang 2,  Pei-Fang Chiu 2,  Tzung-Sheng Lin 2,  Li-Jou Huang 2,  Pi-Hui Liang 2,  Jih-Hwa Guh 2,  Mei-Hsiang Lin 3
Affiliations

Affiliations

  • 1 School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei 110, Taiwan; Department of Pharmacy, Changhua Christian Hospital, Changhua 500, Taiwan.
  • 2 School of Pharmacy, College of Medicine, National Taiwan University, Taipei 100, Taiwan.
  • 3 School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei 110, Taiwan. Electronic address: mhl00001@tmu.edu.tw.
PMID: 41453691 DOI: 10.1016/j.bmcl.2025.130515
Abstract

Abiraterone, a CYP17A1 Inhibitor, is approved by the FDA for castration-resistance prostate Cancer. To mimic the structure of abiraterone, we designed and synthesized nine tetrahydroindeno[4,5-c]chromen-4(3H)-one derivatives with pyridine congeners at C-1 position. Notably, 13c and 14c exhibited the GI50 of 10 nM against PC-3 cells compared to 21.4 μM for abiraterone. The docking studies further revealed that 14c shares a similar binding mode with abiraterone at the CYP17A1 active site.

Keywords

Abiraterone; Antiproliferation; Castration-resistance prostate cancer.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z